FCVTX
Price
$18.75
Change
-$0.77 (-3.94%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

FCVTX vs VSIAX

Header iconFCVTX vs VSIAX Comparison
Open Charts FCVTX vs VSIAXBanner chart's image
Fidelity Advisor Small Cap Value M
Price$18.75
Change-$0.77 (-3.94%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
FCVTX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FCVTX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCVTX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. FCVTX (5.26B). VSIAX pays higher dividends than FCVTX: VSIAX (2.01) vs FCVTX (0.37). FCVTX was incepted earlier than VSIAX: FCVTX (20 years) vs VSIAX (13 years). FCVTX is a more actively managed with annual turnover of: 29.00 vs. VSIAX (16.00). FCVTX has a lower initial minimum investment than VSIAX: FCVTX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. FCVTX (7.94). VSIAX return over 5 years is better than : 52.83 vs. FCVTX (35.67).
FCVTXVSIAXFCVTX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years13 years-
Gain YTD6.78315.03145%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.26B63B8%
Annual Yield % from dividends0.372.0118%
Returns for 1 year7.9416.2349%
Returns for 3 years0.8320.674%
Returns for 5 years35.6752.8368%
Returns for 10 years10.65105.6510%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics